Selected research
Market Structure
Global Leucine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Leucine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Leucine include Ajinomoto Group, Evonik, CJ, KYOWA, Hubei Bafeng Pharmaceutical, Jinghai Amino Acid, JIRONG PHARM, Jiahe Biotech and ChuyuanGroup, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Leucine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Leucine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Leucine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Leucine market size, projected growth trends, production technologies, key applications, and end-use industries.
Leucine Segment by Company
Ajinomoto Group
Evonik
CJ
KYOWA
Hubei Bafeng Pharmaceutical
Jinghai Amino Acid
JIRONG PHARM
Jiahe Biotech
ChuyuanGroup
Siwei Amino Acid
SHINE STAR（HUBEI）BLOLOGICAL
JiangsuShenhua Pharmaceutical
ZhangjiagangxingyuTechnology
Leucine Segment by Type
Food Grade
Feed Grade
Pharmaceutical Grade
Leucine Segment by Application
Food
Feed
Pharmaceuticals
Leucine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leucine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Leucine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leucine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Leucine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leucine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Leucine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Leucine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Feed Grade
- Pharmaceutical Grade
Applications
- Food
- Feed
- Pharmaceuticals
Companies covered
- Ajinomoto Group
- Evonik
- CJ
- KYOWA
- Hubei Bafeng Pharmaceutical
- Jinghai Amino Acid
- JIRONG PHARM
- Jiahe Biotech
- ChuyuanGroup
- Siwei Amino Acid
- SHINE STAR（HUBEI）BLOLOGICAL
- JiangsuShenhua Pharmaceutical
- ZhangjiagangxingyuTechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Leucine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Leucine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Leucine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Leucine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Leucine Market Dynamics
- 2.1 Leucine Industry Trends
- 2.2 Leucine Industry Drivers
- 2.3 Leucine Industry Opportunities and Challenges
- 2.4 Leucine Industry Restraints
3 Leucine Market by Manufacturers
- 3.1 Global Leucine Revenue by Manufacturers (2021-2026)
- 3.2 Global Leucine Sales by Manufacturers (2021-2026)
- 3.3 Global Leucine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Leucine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Leucine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Leucine Manufacturers, Product Type & Application
- 3.7 Global Leucine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Leucine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Leucine Players Market Share by Revenue in 2025
- 3.8.3 2025 Leucine Tier 1, Tier 2, and Tier 3
4 Leucine Market by Type
- 4.1 Leucine Type Introduction
- 4.1.1 Food Grade
- 4.1.2 Feed Grade
- 4.1.3 Pharmaceutical Grade
- 4.2 Global Leucine Sales by Type
- 4.2.1 Global Leucine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Leucine Sales by Type (2021-2032)
- 4.2.3 Global Leucine Sales Market Share by Type (2021-2032)
- 4.3 Global Leucine Revenue by Type
- 4.3.1 Global Leucine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Leucine Revenue by Type (2021-2032)
- 4.3.3 Global Leucine Revenue Market Share by Type (2021-2032)
5 Leucine Market by Application
- 5.1 Leucine Application Introduction
- 5.1.1 Food
- 5.1.2 Feed
- 5.1.3 Pharmaceuticals
- 5.2 Global Leucine Sales by Application
- 5.2.1 Global Leucine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Leucine Sales by Application (2021-2032)
- 5.2.3 Global Leucine Sales Market Share by Application (2021-2032)
- 5.3 Global Leucine Revenue by Application
- 5.3.1 Global Leucine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Leucine Revenue by Application (2021-2032)
- 5.3.3 Global Leucine Revenue Market Share by Application (2021-2032)
6 Global Leucine Sales by Region
- 6.1 Global Leucine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Leucine Sales by Region (2021-2032)
- 6.2.1 Global Leucine Sales by Region (2021-2026)
- 6.2.2 Global Leucine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Leucine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Leucine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Leucine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Leucine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Leucine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Leucine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Leucine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Leucine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Leucine Revenue by Region
- 7.1 Global Leucine Revenue by Region
- 7.1.1 Global Leucine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Leucine Revenue by Region (2021-2026)
- 7.1.3 Global Leucine Revenue by Region (2027-2032)
- 7.1.4 Global Leucine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Leucine Revenue (2021-2032)
- 7.2.2 North America Leucine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Leucine Revenue (2021-2032)
- 7.3.2 Europe Leucine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Leucine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Leucine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Leucine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Leucine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Ajinomoto Group
- 8.1.1 Ajinomoto Group Company Information
- 8.1.2 Ajinomoto Group Business Overview
- 8.1.3 Ajinomoto Group Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Ajinomoto Group Leucine Product Portfolio
- 8.1.5 Ajinomoto Group Recent Developments
- 8.2 Evonik
- 8.2.1 Evonik Company Information
- 8.2.2 Evonik Business Overview
- 8.2.3 Evonik Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Evonik Leucine Product Portfolio
- 8.2.5 Evonik Recent Developments
- 8.3 CJ
- 8.3.1 CJ Company Information
- 8.3.2 CJ Business Overview
- 8.3.3 CJ Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CJ Leucine Product Portfolio
- 8.3.5 CJ Recent Developments
- 8.4 KYOWA
- 8.4.1 KYOWA Company Information
- 8.4.2 KYOWA Business Overview
- 8.4.3 KYOWA Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 KYOWA Leucine Product Portfolio
- 8.4.5 KYOWA Recent Developments
- 8.5 Hubei Bafeng Pharmaceutical
- 8.5.1 Hubei Bafeng Pharmaceutical Company Information
- 8.5.2 Hubei Bafeng Pharmaceutical Business Overview
- 8.5.3 Hubei Bafeng Pharmaceutical Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hubei Bafeng Pharmaceutical Leucine Product Portfolio
- 8.5.5 Hubei Bafeng Pharmaceutical Recent Developments
- 8.6 Jinghai Amino Acid
- 8.6.1 Jinghai Amino Acid Company Information
- 8.6.2 Jinghai Amino Acid Business Overview
- 8.6.3 Jinghai Amino Acid Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Jinghai Amino Acid Leucine Product Portfolio
- 8.6.5 Jinghai Amino Acid Recent Developments
- 8.7 JIRONG PHARM
- 8.7.1 JIRONG PHARM Company Information
- 8.7.2 JIRONG PHARM Business Overview
- 8.7.3 JIRONG PHARM Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 JIRONG PHARM Leucine Product Portfolio
- 8.7.5 JIRONG PHARM Recent Developments
- 8.8 Jiahe Biotech
- 8.8.1 Jiahe Biotech Company Information
- 8.8.2 Jiahe Biotech Business Overview
- 8.8.3 Jiahe Biotech Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Jiahe Biotech Leucine Product Portfolio
- 8.8.5 Jiahe Biotech Recent Developments
- 8.9 ChuyuanGroup
- 8.9.1 ChuyuanGroup Company Information
- 8.9.2 ChuyuanGroup Business Overview
- 8.9.3 ChuyuanGroup Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 ChuyuanGroup Leucine Product Portfolio
- 8.9.5 ChuyuanGroup Recent Developments
- 8.10 Siwei Amino Acid
- 8.10.1 Siwei Amino Acid Company Information
- 8.10.2 Siwei Amino Acid Business Overview
- 8.10.3 Siwei Amino Acid Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Siwei Amino Acid Leucine Product Portfolio
- 8.10.5 Siwei Amino Acid Recent Developments
- 8.11 SHINE STAR（HUBEI）BLOLOGICAL
- 8.11.1 SHINE STAR（HUBEI）BLOLOGICAL Company Information
- 8.11.2 SHINE STAR（HUBEI）BLOLOGICAL Business Overview
- 8.11.3 SHINE STAR（HUBEI）BLOLOGICAL Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 SHINE STAR（HUBEI）BLOLOGICAL Leucine Product Portfolio
- 8.11.5 SHINE STAR（HUBEI）BLOLOGICAL Recent Developments
- 8.12 JiangsuShenhua Pharmaceutical
- 8.12.1 JiangsuShenhua Pharmaceutical Company Information
- 8.12.2 JiangsuShenhua Pharmaceutical Business Overview
- 8.12.3 JiangsuShenhua Pharmaceutical Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 JiangsuShenhua Pharmaceutical Leucine Product Portfolio
- 8.12.5 JiangsuShenhua Pharmaceutical Recent Developments
- 8.13 ZhangjiagangxingyuTechnology
- 8.13.1 ZhangjiagangxingyuTechnology Company Information
- 8.13.2 ZhangjiagangxingyuTechnology Business Overview
- 8.13.3 ZhangjiagangxingyuTechnology Leucine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 ZhangjiagangxingyuTechnology Leucine Product Portfolio
- 8.13.5 ZhangjiagangxingyuTechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Leucine Value Chain Analysis
- 9.1.1 Leucine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Leucine Production Mode & Process
- 9.2 Leucine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Leucine Distributors
- 9.2.3 Leucine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst